Cart
sales@molnova.com
Home - Products - Tyrosine Kinase - BTK - NX-2127

NX-2127

NX-2127

Catalog No. M36530

NX-2127 (ETX2514 Triethylamine) is an orally active BTK inhibitor that induces degradation of mutant BTKC481S in cells.NX-2127 has potent antiproliferative activity and inhibits the proliferation of BTKC481S mutant TMD8 cells.

Size Price / USD Stock Quantity
2MG 166 Get Quote
5MG 258 Get Quote
10MG 407 Get Quote
25MG 656 Get Quote
50MG 908 Get Quote
100MG 1224 Get Quote
500MG 2457 Get Quote
1G Get Quote Get Quote
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    NX-2127
  • Brief Description
  • Description
  • Storage
  • Note
    Research use only, not for human use.
  • Reference
    1. Robbins D W, et al. Nx-2127, a degrader of BTK and IMiD neosubstrates, for the treatment of B-cell malignancies. Blood, 2020, 136: 34.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • RN-486

    A potent and selective BTK inhibitor with IC50 of 4 nM in the enzymatic assay; shows high selectivity against a panel of 369 kinases.

  • Orelabrutinib

    Orelabrutinib is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).

  • BLK degrader 1

    BLK degrader 1 is a selective B lymphoid tyrosine kinase (BLK) degrader with anticancer activity and can be used for cancer research.

Sign In Join Free